明亮光照疗法治疗非季节性抑郁障碍:系统综述与Meta分析
该系统综述与Meta分析纳入2000年至2024年3月发表的11项随机临床试验、共858例非季节性抑郁障碍患者,评估明亮光照疗法(BLT)作为辅助治疗的效果。结果显示BLT组缓解率和应答率均显著优于对照组,亚组分析按随访时间分层仍显示获益,作者认为BLT是有效的辅助治疗,并可能改善初始治疗的应答时间。
要点
- BLT组缓解率40.7% vs 对照组23.5%(OR 2.42,95%CI 1.50-3.91,P<.001)。
- BLT组应答率60.4% vs 对照组38.6%(OR 2.34,95%CI 1.46-3.75,P<.001)。
- 随访<4周和>4周亚组中BLT的缓解与应答率均优于对照组。
核心结论
- 明亮光照疗法是非季节性抑郁障碍的有效辅助治疗。
- 结果提示明亮光照疗法可能改善初始治疗的应答时间。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、Embase和Cochrane数据库至2024年3月,纳入2000年以来发表的随机临床试验。
- 共纳入11项独特试验、858例患者(女性649例,75.6%)。
- 比较明亮光照疗法与暗红光或单用抗抑郁药,采用Mantel-Haenszel法估计差异,用I²统计量评估异质性。
主要发现
- BLT组缓解率40.7% vs 对照组23.5%(OR 2.42,95%CI 1.50-3.91,P<.001,I²=21%)。
- BLT组应答率60.4% vs 对照组38.6%(OR 2.34,95%CI 1.46-3.75,P<.001,I²=41%)。
- 随访<4周亚组:缓解率27.4% vs 9.2%(OR 3.59,95%CI 1.45-8.88,P=.005,I²=0%);应答率55.6% vs 27.4%(OR 3.65,95%CI 1.81-7.33,P<.001,I²=35%)。
- 随访>4周亚组:缓解率46.6% vs 29.1%(OR 2.18,95%CI 1.19-4.00,P=.01,I²=47%);应答率63.0% vs 44.9%(OR 1.79,95%CI 1.01-3.17,P=.04,I²=32%)。
关键数值与推荐
- 纳入标准为2000年以来发表的随机临床试验,比较明亮光照疗法与暗红光或单用抗抑郁药。
- 主要结局为症状缓解、治疗应答率和抑郁量表评分。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Seasonal humor disorders are prone to have a link with daylight exposure. However, the effect of external light on nonseasonal disorders remains unclear. Evidence is lacking for the validity of bright light therapy (BLT) as an adjunctive treatment for these patients. OBJECTIVE: To assess BLT effectiveness as an adjunctive treatment for nonseasonal depressive disorders. DATA SOURCES: In March 2024, a comprehensive search was performed of publications in the MEDLINE, Embase, and Cochrane databases for randomized clinical trials (RCTs) evaluating BLT effects in patients with nonseasonal depression. STUDY SELECTION: RCTs published since 2000 were eligible. Comparisons between BLT and dim red light or antidepressant monotherapy alone were considered for inclusion. DATA EXTRACTION AND SYNTHESIS: Using the systematic review approach on RCTs published from January 1, 2000, through March 25, 2024, differences between patients treated with and without BLT were estimated using the Mantel-Haenszel method; heterogeneity was assessed using I2 statistics. MAIN OUTCOMES AND MEASURES: Remission of symptoms, response to treatment rates, and depression scales were assessed. RESULTS: In this systematic review and meta-analysis of 11 unique trials with data from 858 patients (649 female [75.6%]), statistically significant better remission and response rates were found in the BLT group (remission: 40.7% vs 23.5%; odds ratio [OR], 2.42; 95% CI, 1.50-3.91; P <.001; I2 = 21%; response: 60.4% vs 38.6%; OR, 2.34; 95% CI, 1.46-3.75; P <.001; I2 = 41%). With BLT, subgroup analysis based on follow-up times also showed better remission (<4 weeks: 27.4% vs 9.2%; OR, 3.59; 95% CI, 1.45-8.88; P = .005; I2 = 0% and >4 weeks: 46.6% vs 29.1%; OR, 2.18; 95% CI, 1.19-4.00; P = .01; I2 = 47%) and response (<4 weeks: 55.6% vs 27.4%; OR, 3.65; 95% CI, 1.81-7.33; P <.001; I2 = 35% and >4 weeks: 63.0% vs 44.9%; OR, 1.79; 95% CI, 1.01-3.17; P = .04; I2 = 32%) rates. CONCLUSIONS AND RELEVANCE: Results of this systematic review and meta-analysis reveal that BLT was an effective adjunctive treatment for nonseasonal depressive disorders. Additionally, results suggest that BLT may improve the response time to the initial treatment.
引用
- Menegaz de Almeida A, Aquino de Moraes FC, Cavalcanti Souza ME, et al. Bright Light Therapy for Nonseasonal Depressive Disorders: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2025. PMID: 39356500. doi:10.1001/jamapsychiatry.2024.2871
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。